Article info
PDFNeuromuscular
Research paper
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
- Correspondence to Dr Giuseppe Lauria, 3rd Neurology Unit, Department of Clinical Neurosciences, IRCCS Foundation, “Carlo Besta” Neurological Institute, Via Celoria, 11-20133 Milan, Italy; glauria{at}istituto-besta.it
Citation
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
Publication history
- Received July 15, 2014
- Revised August 26, 2014
- Accepted September 14, 2014
- First published January 16, 2015.
Online issue publication
July 14, 2015
Article Versions
- Previous version (16 January 2015).
- Previous version (9 February 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/